| Rajnikant Mehta, MD | |
|
4000 Wellness Dr, Midland, MI 48670-0001 | |
| (989) 839-1339 | |
| Not Available |
| Full Name | Rajnikant Mehta |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 50 Years |
| Location | 4000 Wellness Dr, Midland, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811924566 | NPI | - | NPPES |
| 320Z910000 | Other | MI | BLUE CROSS |
| 1811924566 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | RM038522 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Midmichigan Medical Center - Alpena | Alpena, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| East Central Radiation Oncology Associates Pc | 1557438520 | 2 |
News Archive
Noninvasive positron emission tomography (PET) imaging may allow earlier prediction of a patient's response to chemotherapy for ovarian cancer, according to research reported at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.
The CAO Group, Inc., the world's top diode laser company, today unveiled the Pilot™ Diode Laser, an innovative surgical and therapeutic instrument that represents a breakthrough for veterinary surgical and therapeutic treatments.
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.
In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients.
› Verified 7 days ago
| Entity Name | East Central Radiation Oncology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407882624 PECOS PAC ID: 1557438520 Enrollment ID: O20080917000811 |
News Archive
Noninvasive positron emission tomography (PET) imaging may allow earlier prediction of a patient's response to chemotherapy for ovarian cancer, according to research reported at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.
The CAO Group, Inc., the world's top diode laser company, today unveiled the Pilot™ Diode Laser, an innovative surgical and therapeutic instrument that represents a breakthrough for veterinary surgical and therapeutic treatments.
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.
In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rajnikant Mehta, MD 4000 Wellness Dr, Midland, MI 48670-0001 Ph: (989) 839-1339 | Rajnikant Mehta, MD 4000 Wellness Dr, Midland, MI 48670-0001 Ph: (989) 839-1339 |
News Archive
Noninvasive positron emission tomography (PET) imaging may allow earlier prediction of a patient's response to chemotherapy for ovarian cancer, according to research reported at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.
The CAO Group, Inc., the world's top diode laser company, today unveiled the Pilot™ Diode Laser, an innovative surgical and therapeutic instrument that represents a breakthrough for veterinary surgical and therapeutic treatments.
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.
In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients.
› Verified 7 days ago
Stephen Pavlock, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Vincent Dimerc, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Richard Montpetit, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Charles A Guidot, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-1644 Fax: 989-839-3029 | |
Michael P Bartlett, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Praful Desai, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Rajesh Kotecha, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-1339 |